Our most recent study, "Brain Cancer Diagnostic Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Diagnostic Type, Cancer Type, End User, Tumor Size, and Geography," predicts that the market will grow at a CAGR of 28.5% from 2022 to 2028, from US$ 1,639.10 million to US$ 7,378.57 million. The research identifies the major drivers boosting the brain cancer diagnostic market's expansion as well as significant market players and their recent product innovations.

Tumor-forming extracellular expansion of brain cells is the primary cause of brain cancer. Both main and secondary brain cancers are present in the tumour. While secondary tumours, sometimes referred to as metastases, are cancers that started in another region of the body, primary brain tumours form in the brain and do not spread to other body parts.

Get Sample Copy of Report PDF: https://www.theinsightpartners.com/sample/TIPRE00024461/

Tumor-forming extracellular expansion of brain cells is the primary cause of brain cancer. Both main and secondary brain cancers are present in the tumour. While secondary tumours, sometimes referred to as metastases, are cancers that started in another region of the body, primary brain tumours form in the brain and do not spread to other body parts. There are 40 major forms of brain tumours, which are further divided into two major groups. Malignant tumours are carcinogenic and more prone to spread, whereas benign tumours are slow-growing and less likely to do so. The global increase in cigarette smokers and the increased incidence of brain cancer are the two main factors contributing to the market growth for brain cancer diagnostics.

The acoustic neuroma, astrocytomas, craniopharyngiomas, ganglioneuromas, glioblastoma multiforme, meningiomas, ependymomas, oligodendroglioma, low-grade tumours, and other brain cancer types are the many cancer kinds that make up the global market for brain cancer diagnostics. The glioblastoma multiforme market category is anticipated to hold the greatest market share in 2021. Additionally, the same market category is anticipated to experience demand development at the highest CAGR from 2021 to 2028 as a result of an increase in the incidence of glioblastoma multiforme on a global scale. As a grade IV astrocytoma, glioblastoma multiforme (GBM) is a rapidly expanding and aggressive brain tumour. Although it penetrates the brain tissue around it, it often does not spread to other organs.

Brain GBMs can arise spontaneously or as a result of a low-grade astrocytoma. Adults with GBM are more frequently affected in the frontal and temporal lobes of the cerebral hemispheres. If untreated, GBM is a deadly brain tumour that can claim a patient's life in as little as six months. Expert neuro-oncological and neurosurgical care must be sought as soon as possible because it may affect overall survival. Brain tumour locations can be precisely determined using sophisticated imaging techniques like computed tomography (CT scan) and magnetic resonance imaging (MRI). Growing consumer knowledge of glioblastoma multiforme is what is fueling market expansion.

Some of the major companies active in the brain cancer diagnostics market include THERMO FISHER SCIENTIFIC INC, Siemens Healthineers AG, GE Healthcare, MDxHealth, NantOmics, Biocept, Inc., Koninklijke Philips N.V., Canon Medical Systems, Hitachi, Ltd., Neusoft Medical Systems, KITZ HEIDELBERG, GENPATH, NVIDIA CORPORATION, ONCORA MEDICAL, BIOMIND

Browse More Related Reports by the insight partners:

Liver Cancer Diagnostics Market

https://www.theinsightpartners.com/reports/liver-cancer-diagnostics-market

Skin Cancer Diagnostics Market

https://www.theinsightpartners.com/reports/skin-cancer-diagnostics-market

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi

E-mail: sales@theinsightpartners.com

Phone: +1-646-491-9876